Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. Yesterday, Dec. 16, 2014, 105 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $63.36 to $15,595,781.10. Highlighted Stocks Traded by Insiders: DigitalGlobe (DGI) - FREE Research Report Zervigon Eddy, who is Director at DigitalGlobe, bought 2,000 shares at $24.84 on Dec. 16, 2014. Following this transaction, the Director owned 5,868 shares meaning that the stake was boosted by 51.71% with the 2,000-share transaction. Wray Grover N., who is SVP, Chief HR Officer at DigitalGlobe, bought 210 shares at $24.61 on Dec. 16, 2014. Following this transaction, the SVP, Chief HR Officer owned 54,166 shares meaning that the stake was boosted by 0.39% with the 210-share transaction. The shares most recently traded at $26.10, up $1.49, or 5.71% since the insider transaction. Historical insider transactions for DigitalGlobe go as follows:
- 4-Week # shares bought: 6,043
- 4-Week # shares sold: 3,000
- 12-Week # shares bought: 9,043
- 12-Week # shares sold: 3,000
- 24-Week # shares bought: 9,043
- 24-Week # shares sold: 21,000
CME Group (CME) - FREE Research Report Harley Jill A, who is Md&Cao at CME Group, sold 400 shares at $87.82 on Dec. 16, 2014. Following this transaction, the Md&Cao owned 11,135 shares meaning that the stake was reduced by 3.47% with the 400-share transaction. The shares most recently traded at $87.50, down $0.32, or 0.37% since the insider transaction. Historical insider transactions for CME Group go as follows:
- 4-Week # shares sold: 450
- 12-Week # shares bought: 350
- 12-Week # shares sold: 3,270
- 24-Week # shares bought: 350
- 24-Week # shares sold: 7,437
Derma (DSCI) - FREE Research Report Conjeevaram Srini, who is Director at Derma, sold 12,500 shares at $8.49 on Dec. 16, 2014. Following this transaction, the Director owned 48,250 shares meaning that the stake was reduced by 20.58% with the 12,500-share transaction. The shares most recently traded at $8.19, down $0.30, or 3.64% since the insider transaction. Historical insider transactions for Derma go as follows:
- 4-Week # shares bought: 3,750
- 4-Week # shares sold: 7,850
- 12-Week # shares bought: 3,750
- 12-Week # shares sold: 17,973
- 24-Week # shares bought: 3,750
- 24-Week # shares sold: 17,973